Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report

A 36-year-old female patient who did not have a previous history of any disease visited our institution because of shortness of breath. The patient was first diagnosed with diabetes upon admission. Chest computed tomography (CT) scan showed a lesion that completely obstructed the left main bronchus...

Full description

Saved in:
Bibliographic Details
Main Authors: Soo Kyun Jung, Keum-Ju Choi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007125000681
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849708547460300800
author Soo Kyun Jung
Keum-Ju Choi
author_facet Soo Kyun Jung
Keum-Ju Choi
author_sort Soo Kyun Jung
collection DOAJ
description A 36-year-old female patient who did not have a previous history of any disease visited our institution because of shortness of breath. The patient was first diagnosed with diabetes upon admission. Chest computed tomography (CT) scan showed a lesion that completely obstructed the left main bronchus and pneumonia. Due to hypoxia, the patient was placed on mechanical ventilation and admitted to the intensive care unit. Bronchoscopy was performed, and results revealed complete atelectasis with a soft tissue mass at the left main bronchus. Bronchoscopic biopsy confirmed that the patient's condition was endobronchial mucormycosis. Treatment with liposomal amphotericin B was started. After 1 week, atelectasis improved based on the chest radiography result. The patient was successfully extubated. However, 4 weeks after treatment, bronchoscopy still showed complete atelectasis with purulent secretion and a soft tissue mass. After 6 weeks, liposomal amphotericin B was switched to isavuconazole, with a duration of 2 months. After completing the treatment, bronchoscopy showed no endobronchial lesion. Herein, we present a rare case of rapidly progressing endobronchial mucormycosis in a young patient who did not have a previous history of any disease and who was successfully managed with pharmacological therapy.
format Article
id doaj-art-9e7afcd3c25f4c8a9ec9d2042f02cd53
institution DOAJ
issn 2213-0071
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj-art-9e7afcd3c25f4c8a9ec9d2042f02cd532025-08-20T03:15:37ZengElsevierRespiratory Medicine Case Reports2213-00712025-01-015610223210.1016/j.rmcr.2025.102232Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case reportSoo Kyun Jung0Keum-Ju Choi1Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, South KoreaCorresponding author.Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea 33, Duryugongwon-ro 17gil, Namgu, Daegu, 42472, South Korea.; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, South KoreaA 36-year-old female patient who did not have a previous history of any disease visited our institution because of shortness of breath. The patient was first diagnosed with diabetes upon admission. Chest computed tomography (CT) scan showed a lesion that completely obstructed the left main bronchus and pneumonia. Due to hypoxia, the patient was placed on mechanical ventilation and admitted to the intensive care unit. Bronchoscopy was performed, and results revealed complete atelectasis with a soft tissue mass at the left main bronchus. Bronchoscopic biopsy confirmed that the patient's condition was endobronchial mucormycosis. Treatment with liposomal amphotericin B was started. After 1 week, atelectasis improved based on the chest radiography result. The patient was successfully extubated. However, 4 weeks after treatment, bronchoscopy still showed complete atelectasis with purulent secretion and a soft tissue mass. After 6 weeks, liposomal amphotericin B was switched to isavuconazole, with a duration of 2 months. After completing the treatment, bronchoscopy showed no endobronchial lesion. Herein, we present a rare case of rapidly progressing endobronchial mucormycosis in a young patient who did not have a previous history of any disease and who was successfully managed with pharmacological therapy.http://www.sciencedirect.com/science/article/pii/S2213007125000681Endobronchial mucormycosisAmphotericine BIsavuconazole
spellingShingle Soo Kyun Jung
Keum-Ju Choi
Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
Respiratory Medicine Case Reports
Endobronchial mucormycosis
Amphotericine B
Isavuconazole
title Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
title_full Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
title_fullStr Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
title_full_unstemmed Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
title_short Endobronchial mucormycosis successfully treated with pharmacologic therapy: A rare case report
title_sort endobronchial mucormycosis successfully treated with pharmacologic therapy a rare case report
topic Endobronchial mucormycosis
Amphotericine B
Isavuconazole
url http://www.sciencedirect.com/science/article/pii/S2213007125000681
work_keys_str_mv AT sookyunjung endobronchialmucormycosissuccessfullytreatedwithpharmacologictherapyararecasereport
AT keumjuchoi endobronchialmucormycosissuccessfullytreatedwithpharmacologictherapyararecasereport